Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer
Clinical trial NCT03125928 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03125928
- Sponsor
- Fox Chase Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-13
- Primary completion
- 2026-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.